Jakeman David

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(12%)(4%)0%0%
Sale Success Rate1 of 60 of 60 of 60 of 60 of 6

Chimerix, Inc.

Drugs » Biotechnology

VP of Finance and Accounting:

Holdings: 141.23K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--